Doris Marko Selected Research

Mycotoxins

1/2021	Endoplasmic Reticulum Adaptation and Autophagic Competence Shape Response to Fluid Shear Stress in T24 Bladder Cancer Cells.
1/2020	Combinatory effects of cereulide and deoxynivalenol on in vitro cell viability and inflammation of human Caco-2 cells.
1/2020	Longitudinal assessment of mycotoxin co-exposures in exclusively breastfed infants.
1/2019	The Fate of Altertoxin II During Tomato Processing Steps at a Laboratory Scale.
12/2018	Functional impairment triggered by altertoxin II (ATXII) in intestinal cells in vitro: cross-talk between cytotoxicity and mechanotransduction.
11/2018	The mycotoxin alternariol suppresses lipopolysaccharide-induced inflammation in THP-1 derived macrophages targeting the NF-κB signalling pathway.
3/2018	Delphinidin protects colon carcinoma cells against the genotoxic effects of the mycotoxin altertoxin II.
1/2018	The Hop Polyphenols Xanthohumol and 8-Prenyl-Naringenin Antagonize the Estrogenic Effects of Fusarium Mycotoxins in Human Endometrial Cancer Cells.
1/2017	Genistein and delphinidin antagonize the genotoxic effects of the mycotoxin alternariol in human colon carcinoma cells.
4/2012	The Alternaria mycotoxins alternariol and alternariol methyl ether induce cytochrome P450 1A1 and apoptosis in murine hepatoma cells dependent on the aryl hydrocarbon receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Doris Marko Research Topics

Disease

30	Carcinoma (Carcinomatosis) 06/2022 - 02/2002
23	Neoplasms (Cancer) 11/2021 - 02/2002
9	Colonic Neoplasms (Colon Cancer) 06/2022 - 04/2005
8	Poisoning 03/2020 - 04/2009
5	Carcinogenesis 04/2013 - 09/2006
4	Body Weight (Weight, Body) 01/2020 - 03/2010
3	Inflammation (Inflammations) 01/2020 - 11/2018
3	Adenocarcinoma 12/2018 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 03/2020 - 04/2012
2	Neoplasm Metastasis (Metastasis) 12/2013 - 09/2009
1	Herpes Zoster 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021
1	Multiple Myeloma 11/2021
1	Leukemia 11/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Starvation 04/2020
1	Malnutrition (Nutritional Deficiencies) 01/2020
1	Infections 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2018
1	Autistic Disorder (Autism) 10/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

17	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 10/2008
10	MycotoxinsIBA 01/2021 - 04/2012
9	Anthocyanins (Anthocyanin)IBA 01/2021 - 04/2009
7	alternariolIBA 01/2022 - 04/2012
6	deoxynivalenolIBA 01/2022 - 01/2016
6	delphinidinIBA 03/2018 - 07/2008
5	GenisteinIBA 01/2022 - 01/2016
5	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2021 - 03/2009
5	PolyphenolsIBA 01/2018 - 04/2005
5	ErbB Receptors (EGF Receptor)IBA 05/2013 - 05/2007
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2010
4	altertoxin IIIBA 01/2020 - 03/2018
4	Pharmaceutical PreparationsIBA 01/2017 - 06/2009
4	Type I DNA Topoisomerases (Topoisomerase I)IBA 11/2016 - 04/2009
4	PoisonsIBA 11/2016 - 03/2009
3	ZearalenoneIBA 01/2022 - 01/2016
3	Phosphotransferases (Kinase)IBA 11/2021 - 09/2009
3	EnzymesIBA 03/2020 - 03/2010
3	IceIBA 03/2020 - 03/2010
3	methylamphotericin B (AME)IBA 01/2020 - 04/2009
3	Estrogens (Estrogen)FDA Link 01/2018 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2014 - 03/2009
2	3-hydroxycholest-7-ene-14-carbaldehydeIBA 01/2022 - 12/2018
2	Transcription Factors (Transcription Factor)IBA 11/2021 - 12/2018
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2020 - 04/2012
2	MicroRNAs (MicroRNA)IBA 10/2019 - 11/2018
2	Alkaline PhosphataseIBA 03/2017 - 01/2017
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2017 - 05/2013
2	Topoisomerase InhibitorsIBA 01/2017 - 10/2016
2	Tenuazonic AcidIBA 01/2016 - 12/2012
2	ResveratrolIBA 12/2015 - 12/2014
2	GlycosidesIBA 04/2013 - 05/2008
2	3-hydroxyflavoneIBA 12/2012 - 07/2008
2	LigandsIBA 12/2012 - 04/2009
2	Coffee FDA Link 10/2011 - 05/2011
2	QuercetinIBA 07/2008 - 09/2006
1	LipidsIBA 06/2022
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 01/2022
1	Claudin-4IBA 01/2022
1	Caveolin 1IBA 01/2022
1	CholesterolIBA 01/2022
1	IntegrinsIBA 01/2022
1	IsotopesIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	OccludinIBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2021
1	TubulinIBA 11/2021
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	CrizotinibIBA 11/2021
1	ProteomeIBA 01/2021
1	AntioxidantsIBA 01/2021
1	Insulin (Novolin)FDA Link 04/2020
1	Messenger RNA (mRNA)IBA 04/2020
1	CytokinesIBA 04/2020
1	trioctyl phosphine oxide (TOPO)IBA 03/2020
1	Food Additives (Food Additive)IBA 03/2020
1	AflatoxinsIBA 03/2020
1	TrichothecenesIBA 01/2020
1	Bacterial ToxinsIBA 01/2020
1	cereulideIBA 01/2020
1	alternariol monomethyl etherIBA 01/2020
1	altertoxin IIBA 01/2020
1	Hormones (Hormone)IBA 01/2019
1	LipopolysaccharidesIBA 11/2018
1	xanthohumolIBA 01/2018
1	8-prenylnaringeninIBA 01/2018
1	3'-oxomethylisoeugenolIBA 11/2016
1	methyleugenol-2',3'-epoxideIBA 11/2016
1	methyleugenol (methyl eugenol)IBA 11/2016
1	Sulfates (Sulfates, Inorganic)IBA 09/2016
1	IsoflavonesIBA 01/2016
1	aurofusarinIBA 01/2016
1	nivalenolIBA 01/2016
1	enniatinsIBA 01/2016

Therapy/Procedure

3	Therapeutics 01/2017 - 12/2004
2	Chemoprevention 04/2013 - 04/2009